Home › Funds › Convergence Investment Partners, LLC › JAZZ
Convergence Investment Partners, LLC position in JAZZ
JAZZ PHARMACEUTICALS PLC · Health Care
Convergence Investment Partners, LLC reported holding 32,094 shares of JAZZ (JAZZ PHARMACEUTICALS PLC) in its Q3 2026 13F filing — a position valued at US$7.4M, representing 0.55% of its reported portfolio and ranking #48 among its reported holdings. Convergence Investment Partners, LLC has disclosed JAZZ holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Convergence Investment Partners, LLC's JAZZ position evolved
Convergence Investment Partners, LLC first disclosed a stake in JAZZ in Q3 2023 at 1,728 shares (US$224K). The position peaked in Q3 2026 at 32,094 shares, worth US$7.4M. Across 8 filings, Convergence Investment Partners, LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 32,094 shares valued at US$7.4M — an increase of 8,431 shares quarter over quarter.. Notable position changes include a 34% increase in Q1 2026 (shares rose 27% over the following quarter), a 55% increase in Q2 2026 (shares fell 4% over the following quarter), a 36% increase in Q3 2026 (shares rose 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.73K | $224.00K | New |
| Q4 2023 | 1.80K | $221.00K | Add |
| Q4 2024 | 8.38K | $1.03M | New |
| Q1 2025 | 10.43K | $1.29M | Add |
| Q4 2025 | 11.38K | $1.93M | New |
| Q1 2026 | 15.29K | $2.89M | Add |
| Q2 2026 | 23.66K | $5.70M | Add |
| Q3 2026 | 32.09K | $7.43M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JAZZ and 13F data
JAZZ (JAZZ PHARMACEUTICALS PLC) is a Health Care company. 42 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$394.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), GMT CAPITAL CORP (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JAZZ
- FULLER & THALER ASSET MANAGEMENT, INC. 1.64M sh · $394.84M · Q2 2026
- MILLENNIUM MANAGEMENT LLC 763.88K sh · $184.07M · Q2 2026
- GMT CAPITAL CORP 453.50K sh · $109.28M · Q2 2026
- Boston Trust Walden Corp 424.57K sh · $98.30M · Q3 2026
More on Convergence Investment Partners, LLC
FAQ
How long has Convergence Investment Partners, LLC held JAZZ?
Convergence Investment Partners, LLC has disclosed JAZZ holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
What is Convergence Investment Partners, LLC's current position in JAZZ?
As of Q3 2026, Convergence Investment Partners, LLC holds 32.09K shares of JAZZ (JAZZ PHARMACEUTICALS PLC), valued at $7.43M, representing 0.55% of its reported portfolio and ranking #48.
Has Convergence Investment Partners, LLC been buying or selling JAZZ?
In the latest 13F filing (Q3 2026), Convergence Investment Partners, LLC increased its position in JAZZ. The position peaked in Q3 2026 at 32.09K shares.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, GMT CAPITAL CORP, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.